Serial Number
99908001
Owner
EPOCH Epigenetics, Inc.Attorney
John Paul OleksiukFiling Date
Jun 26, 2026
EPOCH EPIGENETICS Trademark
Serial Number: 99908001
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
John Paul Oleksiuk Cooley LLP
1299 Pennsylvania Avenue, NW, Suite 700
Washington, DC 20004
United States
Trademark Details
Filing Date
June 26, 2026
Registration Date
Not Registered
Goods & Services
Medical research; Scientific research; Genetic testing for scientific research purposes; Medical and scientific research in the field of cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive disease, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Medical and scientific research in the field of molecular signatures for cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Research laboratory analysis services in the field of cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Blood testing for scientific research purposes
Medical screening; Medical testing services; Genetic testing for medical purposes; Medical screening services in the field of cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive disease, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Medical testing for diagnostic or treatment purposes in the field of molecular signatures for cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical screening services in the field of molecular signatures for cancer, neurologic diseases, cardiovascular diseases, respiratory diseases, gastrointestinal and digestive diseases, hepatic diseases, renal diseases, endocrine diseases, hematologic diseases, autoimmune diseases, and metabolic diseases; Medical testing services of blood serums